Page 2 of 2 FirstFirst 1 2
Results 11 to 18 of 18

Thread: What’s wrong with DSM-V?

  1. #11
    Founder Sheila's Avatar
    Join Date
    Jul 2011
    Location
    Northern California
    Posts
    4,412
    Good stuff!
    Meds free since June 2005.

    "An initiation into shamanic healing means a devaluation of all values, an overturning of the profane world, a peeling away of inveterate handed-down notions of the world, liberation from everything preconceived. For that reason, shamanism is closely connected with suffering. One must suffer the disintegration of one's own system of thought in order to perceive a new world in the higher space."
    -- Holger Kalweit

  2. #12
    Founder Sheila's Avatar
    Join Date
    Jul 2011
    Location
    Northern California
    Posts
    4,412
    Robert D. Stolorow, PhD
    psychologytoday.com
    2 Apr 12

    Deconstructing Psychiatry's Ever-Expanding Bible

    Recent studies have called into question the fifth and latest version of psychiatry’s Diagnostic and Statistical Manual’s creation of new diagnostic entities and categories that are scientifically unsubstantiated and that over-pathologize vulnerable populations such as young children and the elderly. In an earlier blog post (http://www.psychologytoday.com/blog/feeling-relating existing/201202/pathologizing-grief), I criticized the DSM-5 for pathologizing grief by classifying grieving that extends beyond a very short period as a major depressive illness. In this post, I seek to expose and challenge the philosophical presuppositions that underwrite the entire DSM enterprise. These presuppositions descend directly from the metaphysical dualism of Rene Descartes.

    Descartes’s metaphysics divided the finite world into two distinct basic substances: res cogitans and res extensa, thinking substances (minds) with no extension in space and extended substances (bodies and other material things) that do not think. This dualism concretized the idea of a complete separation between mind and world, between subject and object. Descartes’s vision can be characterized as a decontextualization of both mind and world. Mind is isolated from the world in which it dwells, just as the world is purged of all human meaning. In this vision, the mind is pictured as an objective entity that takes its place among other objects, a “thinking thing” that, precisely because it is a thing, is ontologically decontextualized, fundamentally separated from its world.

    The DSM is a pseudo-scientific manual for diagnosing sick Cartesian isolated minds. As such, it completely overlooks the exquisite context sensitivity and radical context dependence of human emotional life and of all forms of emotional disturbance. Against Descartes and his legacy, the DSM, I am contending that all emotional disturbances are constituted in a context of human interrelatedness. One such traumatizing context is characterized by relentless invalidation of emotional experience, coupled with an objectification of the child as being intrinsically defective. No wonder receiving a DSM diagnosis can so often be retraumatizing!

    http://www.psychologytoday.com/blog/...xpanding-bible
    Meds free since June 2005.

    "An initiation into shamanic healing means a devaluation of all values, an overturning of the profane world, a peeling away of inveterate handed-down notions of the world, liberation from everything preconceived. For that reason, shamanism is closely connected with suffering. One must suffer the disintegration of one's own system of thought in order to perceive a new world in the higher space."
    -- Holger Kalweit

  3. #13
    Founder Luc's Avatar
    Join Date
    Jul 2011
    Posts
    4,616
    In this post, I seek to expose and challenge the philosophical presuppositions that underwrite the entire DSM enterprise. These presuppositions descend directly from the metaphysical dualism of Rene Descartes. So well said. That's precisely it. As long as we concentrate on a specific "DSM condition" as being absurd, it doesn't do much in the long run. The point is that the DSM as such misses the point. Again, reductionist vs holistic approach. Dr. Peter Breggin often talks about it (the video below).

    Descartes’s metaphysics divided the finite world into two distinct basic substances: res cogitans and res extensa, thinking substances (minds) with no extension in space and extended substances (bodies and other material things) that do not think. This dualism concretized the idea of a complete separation between mind and world, between subject and object. Descartes’s vision can be characterized as a decontextualization of both mind and world. Mind is isolated from the world in which it dwells, just as the world is purged of all human meaning. In this vision, the mind is pictured as an objective entity that takes its place among other objects, a “thinking thing” that, precisely because it is a thing, is ontologically decontextualized, fundamentally separated from its world.

    The DSM is a pseudo-scientific manual for diagnosing sick Cartesian isolated minds. As such, it completely overlooks the exquisite context sensitivity and radical context dependence of human emotional life and of all forms of emotional disturbance. Against Descartes and his legacy, the DSM, I am contending that all emotional disturbances are constituted in a context of human interrelatedness. One such traumatizing context is characterized by relentless invalidation of emotional experience, coupled with an objectification of the child as being intrinsically defective. No wonder receiving a DSM diagnosis can so often be retraumatizing! Very well put.

    http://www.psychologytoday.com/blog/...xpanding-bible




    On a side note, that's pretty incredible. I was just planning to write today about the Descartes’s metaphysics (the dualism thing) somewhere on the forum.
    Keep walking. Just keep walking.

  4. #14
    Founder Barbara's Avatar
    Join Date
    Jul 2011
    Location
    Northern California
    Posts
    222

    Drug companies look to profit from DSM-5

    Wall Street Journal - Marketwatch
    by Jen Wieczner
    5 Jun 13


    The changes to the DSM-5, the updated manual of psychiatric illnesses released earlier this month, include 15 new mental disorders. Psychiatrists and consumer advocates hope that the new range of diagnoses will help more people find treatment for their suffering. But drug companies could also see a benefit: It’s likely that the changes will expand the demand for prescription medications that could treat these conditions.

    The DSM-5’s changes widen the treatment potential for several mental problems, including depression, premenstrual symptoms, binge eating and dementia. Pharmaceutical experts expect that the DSM-5’s legitimization and expansion of certain disorders will pave the way for companies to develop and sell more drugs to treat them, and increase FDA support for new medications.

    For some drugs, a sales impact could come even before the FDA specifically approves them to treat the new DSM-5 disorders. Doctors often prescribe drugs “off-label” to treat disorders, and broader recognition of the disorders could potentially boost sales of the drugs through those channels.

    Drug makers aren’t allowed to market medications for their off-label uses—indeed, doing so has resulted in costly fines for companies in the past. For now, most pharmaceutical companies are declining to discuss how the DSM-5 might create new uses for existing drugs. But drugs that could be repurposed and repatented for new psychiatric uses could become important profit sources for their manufacturers, clinicians and physicians say, adding that some of the changes in the DSM-5 could create such opportunities.

    Take, for example, the DSM-5’s new guidelines about “bereavement-associated” depression following the loss of a loved one. Previous versions of the DSM recommended against diagnosing major depressive disorder in mourners for eight weeks following a death, but the DSM-5 redacts this “bereavement exclusion.” As a result, says Lisa Cosgrove, a psychologist and professor at the University of Massachusetts in Boston, “what certainly can happen is that, after two weeks, people going through the normal grieving process would then be prescribed an antidepressant.”

    Experts say several major brand-name drugs might be used to treat new DSM-5 disorders. Researchers and companies, for example, are eyeing attention deficit disorder drugs like Shire’s Vyvanse to treat binge eating disorder, along with methylphenidate (commonly known as Novartis’s NVS +0.12% Ritalin), as well as some antidepressants, to treat hoarding. Other studies are looking at seizure drugs such as gabapentin, sold by Pfizer as Neurontin, for cannabis withdrawal. “Presumably the drugs have the opportunity to make more money with that new diagnostic,” says Amanda Roberts, associate professor of molecular neurosciences at The Scripps Research Institute, which specializes in the pharmaceutical industry.

    Shire SHPG -0.04% , which recently began its third phase of binge eating trials with Vyvanse, said in its 2012 annual report that the ADHD drug “now holds the prospect of future growth,” thanks in part to its potential for treating binge eating disorder. “We believe there is a significant unmet patient need for a clinically studied and regulatory approved treatment for the condition,” a Shire spokesperson says. Pfizer PFE +0.75% and Novartis say they only endorse their products for the uses indicated on their labels, which do not currently include hoarding or cannabis withdrawal.

    Some pharma players are openly positioning themselves to take advantage of additions to the DSM-5. The multiple sclerosis drug Sativex, made by GW Pharmaceuticals, which began trading on the Nasdaq May 8, is being tested for treatment of cannabis withdrawal at the University of New South Wales in Australia, using materials donated by the company, according to a university press release and disclosures by the researchers in a separate 2012 study. GW Pharmaceuticals did not respond to a request for comment. Meanwhile, Lightlake Therapeutics (LLTP), a London-based company that just completed Phase II clinical trials for its nasal spray treatment for binge eating disorder, issued a statement following the release of the DSM-5. “We are very pleased to see that binge eating disorder has been added to the APA’s DSM-5,” Roger Crystal, a surgeon and Lightlake CEO, said in the statement. “Inclusion in DSM-5 should help with reimbursement of therapies for BED.”

    Other drugs are likely to get a different kind of boost from the DSM-5—because the manual is recognizing conditions that they’ve already been approved by the FDA to treat. Some Parkinson’s disease medications, for example, are already approved for use for restless legs syndrome, which was added to the psychiatric manual. “I would bet that there are a lot of happy people in the restless-leg pharmaceutical industry right now, because they finally have a real diagnosis,” Roberts says. GlaxoSmithKline’s drug Requip (also available generically) is approved for restless legs syndrome; the company declined to comment on the DSM-5’s potential effect on sales.

    Pharmaceutical companies may already be in position to fill the additional prescriptions that will be written thanks to the DSM-5, some say. Now that psychiatrists can officially diagnose depression even when a patient is still grieving a loved one, experts say there may be a market for specialized antidepressants for mourners. Eli Lilly, for one, supported a clinical trial of its antidepressant Cymbalta for treating “bereavement-associated” depression. While the company says it is not currently evaluating Cymbalta for bereavement, Cosgrove notes that Lilly and other pharmaceutical firms have successfully expanded the uses for their drugs in the past. Some antipsychotic drugs, for example, have eventually been approved by the FDA for depression, bipolar disorder and autism. While Cymbalta was originally approved for diabetic peripheral neuropathy, according to the FDA, in recent years it has gained additional approvals for anxiety, depression, fibromyalgia, and most recently, chronic lower back pain—sometimes after relatively few clinical trials.


    http://www.marketwatch.com/story/new...lls-2013-06-05
    "You must have chaos within you to give birth to a dancing star." -- Nietzsche

  5. #15
    Founder Sheila's Avatar
    Join Date
    Jul 2011
    Location
    Northern California
    Posts
    4,412
    What a diabolically great money-making scheme!

    And there’s so little support in any of our cultures for really facing your demons and doing the hard work of healing whatever it is needs healing in your life. So many people want a pill from an authority figure they look up to.
    Meds free since June 2005.

    "An initiation into shamanic healing means a devaluation of all values, an overturning of the profane world, a peeling away of inveterate handed-down notions of the world, liberation from everything preconceived. For that reason, shamanism is closely connected with suffering. One must suffer the disintegration of one's own system of thought in order to perceive a new world in the higher space."
    -- Holger Kalweit

  6. #16
    Senior Member Junior's Avatar
    Join Date
    Aug 2011
    Location
    Australia
    Posts
    1,290
    Hmm - so 70% of people on the committees for the DSM-V have ties to Big Pharma .... and we've increased the amount of 'illnesses' in the DSM-V .. which opens opportunities for further drug 'treatments' ... It's all becoming clear now


    *shoots self*
    Aropax (Paxil). Currently at 13mg and holding.
    Added Endep (amitrypline) 12.5 for sleep - 11 July 2013


    "There are things that are known and things that are unknown; in between are doors." - Anonymous

  7. #17
    Founder Luc's Avatar
    Join Date
    Jul 2011
    Posts
    4,616


    Natural News

    Thursday, June 13, 2013 by: Mike Bundrant


    Got PMS? Psychiatry has a new mental diagnosis for you

    Back in caveman days I understand that women were sent to the woods during their time of the month.

    Those insensitive cavemen.

    Actually, cavemen fare pretty well compared to modern psychiatrists.

    Psychiatrists just label you mentally disordered if you struggle with your monthly cycle. According to psychiatry's newly revised diagnostic bible, the DSM-5, which I am holding in my hot little hands, women who show typical signs of PMS are diagnosable with a brand new mental illness.

    This ought to go over well.

    On pages 171-172 of the DSM-5, it lists the diagnostic criteria for Premenstrual Dysphoric Disorder, which falls under the code 625.4.

    To qualify for the illustrious mental disorder, you must experience at least five of the following symptoms during the final week before the onset of menses:

    1. Sadness or mood swings
    2. Irritability or anger/increased conflict
    3. Difficulty concentrating
    4. Depressed mood, hopelessness or critical thoughts
    5. Anxiety or tension or a sense of being on edge
    6. Change in appetite
    7. Insomnia or hypersomnia
    8. A sense of overwhelm of feeling out of control
    9. Various physical symptoms: tender breasts, swelling, bloating, pain or weight gain
    10. Lethargy or lack of energy
    11. Decreased interest in common activities (school, work, friends, hobbies, etc..)

    Of course, these symptoms must be a source of "significant stress" and not connected to a different mental illness that you might just as easily qualify for.

    If you do not have at least five of the above symptoms, not to worry. You still qualify for plain old premenstrual syndrome, which millions of women have already been medically branded with.

    Women, which do you prefer? The caveman approach or psychiatry's approach?

    Backlash among women

    Such diagnoses have typically encouraged backlash among women.

    According to Joan Chrisler, PhD, a professor at Connecticut College, menstrual disorders are culture-bound syndromes.

    Paula Caplan, PhD, author of They Say You're Crazy thinks such disorders make a mockery of women. The appalling message, according to Dr. Caplan, is: OK, OK, we'll believe you are feeling bad if we get to call you mentally ill for feeling bad.

    "Can you imagine if we did that to men?" she asks.

    "Women are supposed to be cheerleaders," Dr. Caplan adds. "When a woman is anything but that, she and her family are quick to think something is wrong."

    Worse, medical treatment is rarely in women's long-term benefit. Doctors tend to hand out anti-depressants like they're candy, and this disorder seems like another excuse to do more of the same.


    http://www.naturalnews.com/040749_PM...sychiatry.html
    Keep walking. Just keep walking.

  8. #18
    Founder Sheila's Avatar
    Join Date
    Jul 2011
    Location
    Northern California
    Posts
    4,412
    And what's really scary is this new treatment method of giving women ADs and telling them to take them part of the month every month! Unbelievable!
    Meds free since June 2005.

    "An initiation into shamanic healing means a devaluation of all values, an overturning of the profane world, a peeling away of inveterate handed-down notions of the world, liberation from everything preconceived. For that reason, shamanism is closely connected with suffering. One must suffer the disintegration of one's own system of thought in order to perceive a new world in the higher space."
    -- Holger Kalweit

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts